Pharmacological Strategies to Prevent Restenosis
- 1 March 1996
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 93 (5), 848-852
- https://doi.org/10.1161/01.cir.93.5.848
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.JCI Insight, 1995
- Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy.Hypertension, 1994
- Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II.Hypertension, 1993
- Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury modelAmerican Heart Journal, 1993
- Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta.JCI Insight, 1992
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.Hypertension, 1991
- Role of angiotensin II in injury-induced neointima formation in rats.Hypertension, 1991
- Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs.Hypertension, 1991
- Stimulation of platelet-derived growth factor-induced DNA synthesis by angiotensin II in rabbit vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1990